Form 13-F position report

CERO THERAPEUTICS HLDGS INC

Reported by COWEN AND COMPANY LLC

CEROW CUSIP 71902K113 Manager CIK 0000048966

Reported 687,068 shares, up 48,467 (7.6%) from the prior quarter.

Reported value -68.3%; share count 7.6% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2024
Shares 687,068 Quarter-end amount reported
Reported value $13,810 Fair value at quarter end
Consecutive quarters held 7 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-12-31 2538
2023-03-31 2322
2023-06-30 3543
2023-09-30 4152
2023-12-31 4702
2024-03-31 43552
2024-06-30 13810
2024-09-30 3759
2024-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for CERO THERAPEUTICS HLDGS INC held by COWEN AND COMPANY LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2024 Reduced 0 -737,168 (-100.0%) 0 $0 2025-02-14
Q3 2024 Added 737,168 +50,100 (7.3%) < 0.01% $3,759 2024-11-12
Q2 2024 Added 687,068 +48,467 (7.6%) < 0.01% $13,810 2024-08-07
Q1 2024 Added 638,601 +438,511 (219.2%) < 0.01% $43,552 2024-05-03
Q4 2023 Added 200,090 +142,090 (245.0%) < 0.01% $4,702 2024-02-08
Q3 2023 Unchanged 58,000 0 (0.0%) < 0.01% $4,152 2023-11-09
Q2 2023 Unchanged 58,000 0 (0.0%) < 0.01% $3,543 2023-08-07
Q1 2023 Reduced 58,000 -905 (-1.5%) < 0.01% $2,322 2023-05-09
Q4 2022 New 58,905 +58,905 (0.0%) < 0.01% $2,538 2023-02-09

Who else reported the position

39 managers reported CERO THERAPEUTICS HLDGS INC for Q2 2024.

Managers reporting CERO THERAPEUTICS HLDGS INC in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Atalaya Capital Management LP Reduced 424,867 -133 0.02% $8,497,000 11 qtrs
Context Capital Management LLC Unchanged 122,013 0 < 0.01% $2,452,000 10 qtrs
Silver Rock Financial LP Unchanged 12,224 0 < 0.01% $246,000 7 qtrs
HIGHBRIDGE CAPITAL MANAGEMENT LLC Added 829,598 +1,054 < 0.01% $16,592 11 qtrs
COWEN AND COMPANY LLC This report Added 687,068 +48,467 < 0.01% $13,810 7 qtrs
CANTOR FITZGERALD L P Unchanged 441,048 0 < 0.01% $8,865 11 qtrs
Periscope Capital Inc Reduced 427,634 -163,866 < 0.01% $8,595 10 qtrs
MMCAP International Inc SPC Unchanged 375,000 0 < 0.01% $7,538 11 qtrs
Saba Capital Management L P Unchanged 295,913 0 < 0.01% $5,948 11 qtrs
Linden Advisors LP Unchanged 249,999 0 < 0.01% $5,625 10 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 07, 2024
Filing type
13F-HR
Position type
*W EXP 02/13/202

Voting authority reported

Sole
687,068
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.